Clinical trial
Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic…
NCT00153140 · Braintree Laboratories, Industry · Completed
Key facts
| NCT number | NCT00153140 |
|---|---|
| Title | Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation |
| Official title | Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation |
| Lead sponsor | Braintree Laboratories, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Constipation |
| Intervention type | Drug |
| Interventions | polyethyleneglycol3350 |
| Enrollment | 239 |
| Start date | Jul 1, 2004 |
| Primary completion | Oct 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 7, 2013 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: